PRL and breast carcinoma: To evaluate the relevance of PR isoform expression and ratio on the regulatory activity of prolactin for FASN gene expression, we used the PR-A/PR-B-positive (T47Dco) and PR-null (T47D-Y) variants of the estrogen receptor (ER)/PR-positive breast cancer cell line T47D.